Literature DB >> 16571801

Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.

Jae-Hyung Lee1, Sean C Murphy, Michael Belshan, Wendy O Sparks, Yvonne Wannemuehler, Sijun Liu, Thomas J Hope, Drena Dobbs, Susan Carpenter.   

Abstract

Equine infectious anemia virus (EIAV) Rev is an essential regulatory protein that facilitates expression of viral mRNAs encoding structural proteins and genomic RNA and regulates alternative splicing of the bicistronic tat/rev mRNA. EIAV Rev is characterized by a high rate of genetic variation in vivo, and changes in Rev genotype and phenotype have been shown to coincide with changes in clinical disease. To better understand how genetic variation alters Rev phenotype, we undertook deletion and mutational analyses to map functional domains and to identify specific motifs that are essential for EIAV Rev activity. All functional domains are contained within the second exon of EIAV Rev. The overall organization of domains within Rev exon 2 includes a nuclear export signal, a large central region required for RNA binding, a nonessential region, and a C-terminal region required for both nuclear localization and RNA binding. Subcellular localization of green fluorescent protein-Rev mutants indicated that basic residues within the KRRRK motif in the C-terminal region of Rev are necessary for targeting of Rev to the nucleus. Two separate regions of Rev were necessary for RNA binding: a central region encompassing residues 57 to 130 and a C-terminal region spanning residues 144 to 165. Within these regions were two distinct, short arginine-rich motifs essential for RNA binding, including an RRDRW motif in the central region and the KRRRK motif near the C terminus. These findings suggest that EIAV Rev utilizes a bipartite RNA-binding domain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16571801      PMCID: PMC1440447          DOI: 10.1128/JVI.80.8.3844-3852.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Protein secondary structure prediction based on position-specific scoring matrices.

Authors:  D T Jones
Journal:  J Mol Biol       Date:  1999-09-17       Impact factor: 5.469

Review 2.  Transport of proteins and RNAs in and out of the nucleus.

Authors:  S Nakielny; G Dreyfuss
Journal:  Cell       Date:  1999-12-23       Impact factor: 41.582

3.  Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.

Authors:  M Belshan; P Baccam; J L Oaks; B A Sponseller; S C Murphy; J Cornette; S Carpenter
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

4.  Cascaded multiple classifiers for secondary structure prediction.

Authors:  M Ouali; R D King
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

5.  Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.

Authors:  D Derse
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

6.  RNA target specificity of the STAR/GSG domain post-transcriptional regulatory protein GLD-1.

Authors:  Sean P Ryder; Leah A Frater; Dana L Abramovitz; Elizabeth B Goodwin; James R Williamson
Journal:  Nat Struct Mol Biol       Date:  2003-12-29       Impact factor: 15.369

7.  Combining the GOR V algorithm with evolutionary information for protein secondary structure prediction from amino acid sequence.

Authors:  A Kloczkowski; K-L Ting; R L Jernigan; J Garnier
Journal:  Proteins       Date:  2002-11-01

8.  Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.

Authors:  Prasith Baccam; Robert J Thompson; Yuxing Li; Wendy O Sparks; Michael Belshan; Karin S Dorman; Yvonne Wannemuehler; J Lindsay Oaks; James L Cornette; Susan Carpenter
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.

Authors:  C Leroux; C J Issel; R C Montelaro
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

10.  cis-Acting and trans-acting modulation of equine infectious anemia virus alternative RNA splicing.

Authors:  Huey-Jane Liao; Carl C Baker; Gerald L Princler; David Derse
Journal:  Virology       Date:  2004-05-20       Impact factor: 3.616

View more
  13 in total

1.  The bovine immunodeficiency virus Rev protein: identification of a novel nuclear import pathway and nuclear export signal among retroviral Rev/Rev-like proteins.

Authors:  Andrea Gomez Corredor; Denis Archambault
Journal:  J Virol       Date:  2012-02-29       Impact factor: 5.103

2.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

3.  Naturally arising point mutations in non-essential domains of equine infectious anemia virus Rev alter Rev-dependent nuclear-export activity.

Authors:  Wendy O Sparks; Karin S Dorman; Sijun Liu; Susan Carpenter
Journal:  J Gen Virol       Date:  2008-04       Impact factor: 3.891

4.  The bovine immunodeficiency virus rev protein: identification of a novel lentiviral bipartite nuclear localization signal harboring an atypical spacer sequence.

Authors:  Andrea Gomez Corredor; Denis Archambault
Journal:  J Virol       Date:  2009-10-14       Impact factor: 5.103

Review 5.  Rev variation during persistent lentivirus infection.

Authors:  Susan Carpenter; Wei-Chen Chen; Karin S Dorman
Journal:  Viruses       Date:  2011-01-11       Impact factor: 5.818

6.  Computational modeling suggests dimerization of equine infectious anemia virus Rev is required for RNA binding.

Authors:  Chijioke N Umunnakwe; Hyelee Loyd; Kinsey Cornick; Jerald R Chavez; Drena Dobbs; Susan Carpenter
Journal:  Retrovirology       Date:  2014-12-23       Impact factor: 4.602

7.  Identification of a homogenous structural basis for oligomerization by retroviral Rev-like proteins.

Authors:  Chijioke N Umunnakwe; Karin S Dorman; Drena Dobbs; Susan Carpenter
Journal:  Retrovirology       Date:  2017-08-22       Impact factor: 4.602

8.  The Jembrana disease virus Rev protein: Identification of nuclear and novel lentiviral nucleolar localization and nuclear export signals.

Authors:  Claude Marchand; Guy Lemay; Denis Archambault
Journal:  PLoS One       Date:  2019-08-22       Impact factor: 3.240

9.  Structural model of the Rev regulatory protein from equine infectious anemia virus.

Authors:  Yungok Ihm; Wendy O Sparks; Jae-Hyung Lee; Haibo Cao; Susan Carpenter; Cai-Zhuang Wang; Kai-Ming Ho; Drena Dobbs
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

10.  Analysis of the EIAV Rev-responsive element (RRE) reveals a conserved RNA motif required for high affinity Rev binding in both HIV-1 and EIAV.

Authors:  Jae-Hyung Lee; Gloria Culver; Susan Carpenter; Drena Dobbs
Journal:  PLoS One       Date:  2008-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.